| Name | 1-[3-(Trifluoromethyl)pyridin-2-yl]-1,4-diazepane |
|---|---|
| Synonyms |
1-[3-(trifluoromethyl)-2-pyridinyl]piperazine
1H-1,4-Diazine, hexahydro-1-[3-(trifluoromethyl)-2-pyridinyl] 1-(3-(trifluoromethyl)-pyridin-2-yl)piperazine BUTTPK 27 Piperazine,1-[3-(trifluoromethoxy)phenyl] 1-[3-(TRIFLUOROMETHYL)PYRID-2-YL]-1,4-DIAZANE 1-(3-trifluoromethoxy-phenyl)-piperazine 1-(3-(trifluoromethyl)pyridin-2-yl)-1,4-diazepane 1-[3-(TRIFLUOROMETHYL)PYRID-2-YL]HOMOPIPERAZINE Hexahydro-1-[3-(trifluoromethyl)-2-pyridinyl]-1H-1,4-diazine 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine 1-[3-(trifluoromethyl)-2-pyridyl]-1,4-diazepane 1-[3-(Trifluoromethyl)pyridin-2-yl]homopiperazine, 2-(1,4-Diazan-1-yl)-3-(trifluoromethyl)pyridine |
| Molecular Formula | C11H14F3N3 |
|---|---|
| Molecular Weight | 245.24400 |
| Exact Mass | 245.11400 |
| PSA | 28.16000 |
| LogP | 2.29390 |
|
~93%
243666-15-1 |
| Literature: ASTRAZENECA AB; ASTRAZENECA UK LIMITED Patent: WO2007/122411 A1, 2007 ; Location in patent: Page/Page column 28 ; WO 2007/122411 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |